PROQR THERAPEUTICS (Germany) Performance
| 0PQ Stock | EUR 1.71 0.12 6.56% |
The company holds a Beta of 0.73, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PROQR THERAPEUTICS's returns are expected to increase less than the market. However, during the bear market, the loss of holding PROQR THERAPEUTICS is expected to be smaller as well. PROQR THERAPEUTICS has an expected return of -0.0216%. Please make sure to check PROQR THERAPEUTICS jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if PROQR THERAPEUTICS performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days PROQR THERAPEUTICS EO 04 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, PROQR THERAPEUTICS is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
PROQR |
PROQR THERAPEUTICS Relative Risk vs. Return Landscape
If you would invest 183.00 in PROQR THERAPEUTICS EO 04 on January 24, 2024 and sell it today you would lose (12.00) from holding PROQR THERAPEUTICS EO 04 or give up 6.56% of portfolio value over 90 days. PROQR THERAPEUTICS EO 04 is currently producing negative expected returns and takes up 4.229% volatility of returns over 90 trading days. Put another way, 37% of traded stocks are less volatile than PROQR, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
PROQR THERAPEUTICS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PROQR THERAPEUTICS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PROQR THERAPEUTICS EO 04, and traders can use it to determine the average amount a PROQR THERAPEUTICS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0051
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0PQ |
Estimated Market Risk
| 4.23 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PROQR THERAPEUTICS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PROQR THERAPEUTICS by adding PROQR THERAPEUTICS to a well-diversified portfolio.
PROQR THERAPEUTICS Fundamentals Growth
PROQR Stock prices reflect investors' perceptions of the future prospects and financial health of PROQR THERAPEUTICS, and PROQR THERAPEUTICS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PROQR Stock performance.
| Return On Equity | -0.75 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (16.95) % | |||
| Shares Outstanding | 71.43 M | |||
| Revenue | 3.93 M | |||
| EBITDA | (66 M) | |||
| Cash And Equivalents | 75.84 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 34.28 M | |||
| Debt To Equity | 0.61 % | |||
| Book Value Per Share | 0.91 X | |||
| Cash Flow From Operations | (47.06 M) | |||
| Earnings Per Share | (0.92) X | |||
About PROQR THERAPEUTICS Performance
To evaluate PROQR THERAPEUTICS Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when PROQR THERAPEUTICS generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare PROQR Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand PROQR THERAPEUTICS market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents PROQR's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands. PROQR THERAPEUTICS is traded on Frankfurt Stock Exchange in Germany.Things to note about PROQR THERAPEUTICS performance evaluation
Checking the ongoing alerts about PROQR THERAPEUTICS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PROQR THERAPEUTICS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PROQR THERAPEUTICS generated a negative expected return over the last 90 days | |
| PROQR THERAPEUTICS may become a speculative penny stock | |
| PROQR THERAPEUTICS has high historical volatility and very poor performance | |
| The company reported the revenue of 3.93 M. Net Loss for the year was (46.56 M) with profit before overhead, payroll, taxes, and interest of 2.4 M. | |
| PROQR THERAPEUTICS EO 04 has accumulated about 75.84 M in cash with (47.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
- Analyzing PROQR THERAPEUTICS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PROQR THERAPEUTICS's stock is overvalued or undervalued compared to its peers.
- Examining PROQR THERAPEUTICS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PROQR THERAPEUTICS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PROQR THERAPEUTICS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PROQR THERAPEUTICS's stock. These opinions can provide insight into PROQR THERAPEUTICS's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PROQR THERAPEUTICS EO 04. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for PROQR Stock analysis
When running PROQR THERAPEUTICS's price analysis, check to measure PROQR THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PROQR THERAPEUTICS is operating at the current time. Most of PROQR THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of PROQR THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PROQR THERAPEUTICS's price. Additionally, you may evaluate how the addition of PROQR THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |